Grading of Gliomas: The Road From Eminence to Evidence
- 1 February 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 70 (2), 101-109
- https://doi.org/10.1097/nen.0b013e31820681aa
Abstract
The development of concise grading schemes for diffuse gliomas with proven relevance to tumor behavior and susceptibility to therapy is important for clinical decision making. At present, there is unacceptably large interobserver discrepancy in the application of the current World Health Organization (WHO) criteria for accrual of patients in trials for patients with gliomas. Because of a lack of relevant studies, the WHO guidelines for grading are not yet as clear aswould be desirable. The development of well-defined grading schemes consisting of features with low interobserver scoring variability and prognostic or predictive relevance is needed. Although interobserver concordance can be tested in retrospective studies, the prognostic or predictive qualities of histological parameters can only be tested in prospective studies. Only evidence-based histopathology will retain its critical role in the diagnosis and treatment of diffuse gliomas.Keywords
This publication has 71 references indexed in Scilit:
- Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951Neuro-Oncology, 2009
- Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma NetworkJournal of Clinical Oncology, 2009
- A multigene predictor of outcome in glioblastomaNeuro-Oncology, 2009
- The 2007 WHO Classification of Tumors of the Nervous System: Controversies in Surgical NeuropathologyBrain Pathology, 2008
- Gene Expression-Based Molecular Diagnostic System for Malignant Gliomas Is Superior to Histological DiagnosisClinical Cancer Research, 2007
- Cerebral Blood Volume Measurements and Proton MR Spectroscopy in Grading of Oligodendroglial TumorsAmerican Journal of Roentgenology, 2007
- A multicenter study of the prognosis and treatment of adult brain ependymal tumorsCancer, 2004
- The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical eraCancer, 2004
- Quantitative Histologic Factors for Grouping Childhood Supratentorial Neuroglial TumorsPediatric Pathology & Laboratory Medicine, 1997
- A Long Term Study of Patients with OligodendrogliomasJournal of Neurosurgery, 1966